Regulation of glutamate in cultures of human monocytic THP-1 and astrocytoma U-373 MG cells

Journal of Neuroimmunology

Volumn 78, Issue 1-2, 1997, Pages 152-161

  Klegeris, A ^a   Walker, D G ^a   McGeer, P L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Amyloid peptide; Alzheimer's disease; Cytokines; Excitotoxicity; Inflammation; Microglia

Indexed keywords

AMYLOID BETA PROTEIN; GAMMA INTERFERON; GLUTAMIC ACID; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR; ZYMOSAN;

ALZHEIMER DISEASE; AMINO ACID METABOLISM; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTOMA; CELL VIABILITY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; MONOCYTE; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; PHAGOCYTOSIS; PRIORITY JOURNAL; TUMOR CELL CULTURE;

AMYLOID BETA-PROTEIN; ANTI-INFLAMMATORY AGENTS; ASTROCYTOMA; CELL LINE; DEXAMETHASONE; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; HUMANS; INFLAMMATION MEDIATORS; MONOCYTES; PEPTIDE FRAGMENTS; PIMELIC ACIDS;

EID: 0030774899     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00094-5     Document Type: Article

References (79)

1. Alliot F., Marty M.-C., Cambier D., Pessac B. A spontaneously immortalized mouse microglial cell line expressing CD4. Dev. Brain Res. 95:1996;140-143.
2. Auwerx J., Staels B., Van Vaeck F., Ceuppens J.L. Changes in IgG Fc receptor expression induced by phorbol 12-myristate 13-acetate treatment of THP-1 monocytic leukemia cells. Leukemia Res. 16:1992;317-327.
3. Barnum S.R., Jones J.L. Differential regulation of C3 gene expression in human astroglioma cells by interferon-γ and interleukin-1β Neurosci. Lett. 197:1995;121-124.
4. Beutler, H.-O., Michal, G., 1974. L-Glutamate. Determination with glutamate dehydrogenase, diaphorase, and tetrazolium salts. In: Bergmeyer, H.U., Gawehn, K. (Eds.), Methods of Enzymatic Analysis, vol. 4. Academic Press, New York, NY, pp. 1708-1713.
5. Boumpas D.T., Paliogianni F., Anastassiou E.D., Balow J.E. Glucocorticosteroids action on the immune system: Molecular and cellular aspects. Clin. Exp. Rheumatol. 9:1991;413-423.
6. Cho Y., Bannai S. Uptake of glutamate and cystine in C-6 glioma cells and in cultured astrocytes. J. Neurochem. 55:1990;2091-2097.
7. Choi K.T., Chung J.K., Kwak C.S., Kim H.K. Effect of hypocapnia on extracellular glutamate and glycine concentrations during the periischemic period in rabbit hippocampus. Ann. N.Y. Acad. Sci. 765:1995;86-97.
8. Costa Rosa L.-F.B.P., Cury Y., Curi R. Hormonal control of macrophage function and glutamine metabolism. Biochem. Cell Biol. 69:1991;309-312.
9. 2 metabolism. Biochem. J. 310:1995;709-714.
10. Curthoys N.P., Watford M. Regulation of glutaminase activity and glutamine metabolism. Annu. Rev. Nutr. 15:1995;133-159.
11. Decker T., Lohmann-Matthes M.-L. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J. Immunol. Methods. 15:1988;61-69.
12. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.-H.C., Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia. 7:1994;75-83.
13. Dodd P.R., Scott H.L., Westphalen R.I. Excitotoxic mechanisms in the pathogenesis of dementia. Neurochem. Int. 25:1994;203-219.
14. Dreyer E.B., Lipton S.A. The coat protein gp120 of HIV-1 inhibits astrocyte uptake of excitatory amino acids via macrophage arachidonic acid. Eur. J. Neurosci. 7:1995;2502-2507.
15. Drejer J., Larsson O.M., Schousboe A. Characterization of L-glutamate uptake into and release from astrocytes and neurons cultured from different brain regions. Exp. Brain Res. 47:1982;259-269.
16. Driscoll B.F., Deibler G.E., Law M.J., Crane A.M. Damage to neurons in culture following medium change: Role of glutamine and extracellular generation of glutamate. J. Neurochem. 61:1993;1795-1800.
17. El Khoury J., Hickman S.E., Thomas C.A., Cao L., Silverstein S.C., Loike J.D. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature. 382:1996;716-719.
18. Erecinska M., Silver I.A. Metabolism and role of glutamate in mammalian brain. Prog. Neurobiol. 35:1990;245-296.
19. Ezekowitz R.A.B., Sim R.B., Hill M., Gordon S. Local opsonization by secreted macrophage complement components. J. Exp. Med. 159:1984;244-260.
20. Fahrig T. Receptor subtype involved and mechanism of norepinephrine-induced stimulation of glutamate uptake into primary cultures of rat brain astrocytes. Glia. 7:1993;212-218.
21. Fine S.M., Angel R.A., Perry S.W., Epstein L.G., Rothstein J.D., Dewhurst S., Gelbard H.A. Tumor necrosis factor α inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia. J. Biol. Chem. 271:1996;15303-15306.
22. Frederickson R.C.A. Astroglia in Alzheimer's disease. Neurobiol. Aging. 13:1992;239-253.
23. Gasque P., Fontaine M., Morgan B.P. Complement expression in human brain. Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines. J. Immunol. 154:1995;4726-4733.
24. Gasque P., Chan P., Mauger C., Schouft M.T., Singhrao S., Dierich M.P., Morgan B.P., Fontaine M. Identification and characterization of complement C3 receptors on human astrocytes. J. Immunol. 156:1996;2247-2255.
25. Gehrmann J., Matsumoto Y., Kreutzberg G.W. Microglia: Intrinsic immuneffector cell of the brain. Brain Res. Rev. 20:1995;269-287.
26. Gitter B.D., Cox L.M., Rydel R.E., May P.C. Amyloid β peptide potentiates cytokine secretion by interleukin-1β-activated human astrocytoma cells. Proc. Natl. Acad. Sci. USA. 92:1995;10738-10741.
27. Gomeza J., Casado M., Gimenez C., Aragon C. Inhibition of high-affinity γ-aminobutyric acid uptake in primary astrocyte cultures by phorbol esters and phospholipase C. Biochem. J. 275:1991;349-435.
28. Greenamyre J.T., Young A.B. Excitatory amino acids and Alzheimer's disease. Neurobiol. Aging. 10:1989;593-602.
29. Harris M.E., Carney J.M., Cole P.S., Hensley K., Howard B.J., Martin L., Bummer P., Wang Y., Pedigo N.W. Jr., Butterfield D.A. β-Amyloid peptide-derived, oxygen dependent free radicals inhibit glutamate uptake in cultured astrocytes: Implications for Alzheimer's disease. Neuroreport. 6:1995;1875-1879.
30. 2 in a murine model of inflammation: Possible role of cyclooxygenase-2. Proc. Natl. Acad. Sci. USA. 93:1996;4885-4890.
31. Hu S., Sheng W.S., Peterson P.K., Chao C.C. Differential regulation by cytokines of human astrocyte nitric oxide production. Glia. 15:1995;491-494.
32. Jackson M.J., Zielke H.R., Max S.R. Effect of dibutyryl cyclic AMP and dexamethasone on glutamine synthetase gene expression in rat astrocytes in culture. Neurochem. Res. 20:1995;201-207.
33. Kawamata T., Akiyama H., Yamada T., McGeer P.L. Immunological reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am. J. Pathol. 40:1992;691-707.
34. Klegeris A., McGeer P.L. Inhibition of respiratory burst in macrophages by complement receptor blockade. Eur. J. Pharmacol. 260:1994;273-277.
35. Klegeris A., Walker D.G., McGeer P.L. Activation of macrophages by Alzheimer β amyloid peptide. Biochem. Biophys. Res. Commun. 199:1994;984-991.
36. Klegeris A., Walker D.G., McGeer P.L. Interaction of Alzheimer β-amyloid peptide with the human monocytic cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factor-α Brain Res. 747:1997;114-121.
37. Krych M., Atkinson J.P., Holers V.M. Complement receptors. Curr. Opin. Immunol. 4:1992;8-13.
38. Kubin M., Chow J.M., Trinchieri G. Differential regulation of interleukin-12, tumor necrosis factor α, and IL-1β production in human myeloid leukemia cell lines and peripheral blood mononuclear cells. Blood. 83:1994;1847-1855.
39. Lees G.J. The possible contribution of microglia and macrophages to delayed neuronal death after ischemia. J. Neurol. Sci. 114:1993;119-122.
40. Legoux P., Minty C., Delpech B., Minty A.J., Shire D. Simultaneous quantitation of cytokine mRNAs in interleukin-1β stimulated U373 human astrocytoma cells by a polymerase chain reaction method involving co-amplification with an internal multi-specific control. Eur. Cytokine Network. 3:1992;553-563.
41. Lehmann A., Isacsson H., Hamberger A. Effects of in vivo administration of kainic acid on the extracellular amino acid pool in the rabbit hippocampus. J. Neurochem. 40:1983;1314-1320.
42. Lieb K., Kaltschmidt C., Kaltschmidt B., Baeuerle P.A., Berger M., Bauer J., Fiebich B.L. Interleukin-1β uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor α genes in the human astrocytoma cell line U373. J. Neurochem. 66:1996;1496-1503.
43. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. New Engl. J. Med. 330:1994;613-622.
44. Lorton D., Kocsis J.-M., King L., Madden K., Brunden K.R. β-Amyloid induces increased release of interleukin-1β from lipopolysaccharide-activated human monocytes. J. Neuroimmunol. 67:1996;21-29.
45. McGeer E.G., McGeer P.L. Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids. Nature. 263:1976;517-519.
46. McGeer P.L., McGeer E.G. The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 263:1995;517-519.
47. McGeer P.L., Itagaki S., Tago H., McGeer E.G. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci. Lett. 79:1987;195-200.
48. McGeer P.L., Itagaki S., McGeer E.G. Expression of the histocompatibility glycoprotein HLA-DR in neurological disease. Acta. Neuropathol. 76:1988;550-557.
49. McGeer P.L., Schulzer M., McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiological studies. Neurology. 47:1996;425-432.
50. Meda L., Cassatella M.A., Szendrei G.I., Otvos L. Jr., Baron P., Villalba M., Ferrari D., Rossi F. Activation of microglial cells by β-amyloid protein and interferon-γ Nature. 374:1995;647-650.
51. Munsat T.L., Hollander D. Excitotoxins and amyotrophic lateral sclerosis. Therapie. 45:1990;277-279.
52. Murphy G.M. Jr., Lee Y.L., Jia X.C., Yu A.C., Majewska A., Song Y., Schmidt K., Eng L.F. Tumor necrosis factor-α and basic fibroblast growth factor decrease glial fibrillary acidic protein and its encoding mRNA in astrocyte cultures and glioblastoma cells. J. Neurochem. 65:1995;2716-2724.
53. Nadler, J.V., Perry, B.W., Cotman, C.W., 1978. Preferential vulnerability of hippocampus to intraventricular kainic acid. In: McGeer, E.G., Olney, J.W., McGeer, P.L. (Eds.), Kainic Acid as a Tool in Neurobiology. Raven Press, New York, pp. 219-237.
54. Newsholme P., Newsholme E.A. Rates of utilization of glucose, glutamine and oleate and formation of end-products by mouse peritoneal macrophages in culture. Biochem. J. 261:1989;211-218.
55. Newsholme P., Gordon S., Newsholme E.A. Rates of utilization and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophages. Biochem. J. 242:1987;631-636.
56. Nicholls D., Attwell D. The release and uptake of excitatory amino acids. Trends Pharmacol. Sci. 11:1990;462-468.
57. 2 by LPS-stimulated rat bone marrow macrophages after thermal injury: Effect of indomethacin. Inflammation. 18:1994;175-185.
58. Olney, J.W., 1978. Neurotoxicity of excitatory amino acids. In: McGeer, E.G., Olney, J.W., McGeer, P.L. (Eds.), Kainic Acid as a Tool in Neurobiology. Raven Press, New York, pp. 95-121.
59. Patrizio M., Levi G. Glutamate production by cultured microglia: Differences between rat and mouse, enhancement by lipopolysaccharide and lack effect of HIV coat protein gp120 and depolarizing agents. Neurosci. Lett. 178:1994;184-188.
60. Pellegrini-Giampietro D.E., Cherici G., Alesiani M., Carla V., Moroni F. Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. J. Neurosci. 10:1990;1035-1041.
61. Phillis J.W., Smith-Barbour M., Perkins L.M., O'Regan M.H. Indomethacin modulates ischemia-evoked release of glutamate and adenosine from the rat cerebral cortex. Brain Res. 652:1994;353-356.
62. - in the macrophage-induced glutamate-dependent cytotoxicity to neurons. J. Immunol. 152:1994;3578-3585.
63. Piani D., Frei K., Do K.Q., Cuenod M., Fontana A. Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci. Lett. 133:1991;159-162.
64. Piani D., Frei K., Pfister H.-W., Fontana A. Glutamate uptake by astrocytes is inhibited by reactive oxygen intermediates but not by other macrophage-derived molecules including cytokines, leukotrienes or platelet-activating factor. J. Neuroimmunol. 48:1993;99-104.
65. Prieto J., Eklund A., Patarroyo M. Regulated expression of integrins and other adhesion molecules during differentiation of monocytes into macrophages. Cell. Immunol. 156:1994;191-211.
66. Rogers J., Kirby L.C., Hempelman S.R., Berry D.L., McGeer P.L., Kaszniak A.W., Zalinski J., Cofield M., Mansukhani L., Willson P., Kogan F. Clinical trial of indomethacin in Alzheimer's disease. Neurology. 43:1993;1609-1611.
67. Sato H., Fujiwara K., Sagara J., Bannai S. Induction of cystine transport activity in mouse peritoneal macrophages by bacterial lipopolysaccharide. Biochem. J. 310:1995;547-551.
68. 3. J. Leuk. Biol. 59:1996;555-561.
69. Scott H.L., Tannenberg A.E., Dodd P.R. Variant forms of neuronal glutamate transporter sites in Alzheimer's disease cerebral cortex. J. Neurochem. 64:1995;2193-2202.
70. Shaffer L.M., Dority M.D., Gupta-Bansal R., Frederickson R.C.A., Younkin S.G., Brunden K.R. Amyloid β protein (Aβ) removal by neuroglial cells in culture. Neurobiol. Aging. 16:1995;737-745.
71. Taylor C.P., Geer J.J., Burke S.P. Endogenous extracellular glutamate accumulation in rat neocortical cultures by reversal of the transmembrane sodium gradient. Neurosci. Lett. 145:1992;197-200.
72. Van Meir E.G. Cytokines and tumors of the central nervous system. Glia. 15:1995;264-288.
73. Van Muiswinkel F.L., Veerhuis R., Eikelenboom P. Amyloid β protein primes cultured rat microglial cells for an enhanced phorbol 12-myristate 13-acetate-induced respiratory burst activity. J. Neurochem. 66:1996;2468-2476.
74. Volterra A., Trotti D., Tromba C., Floridi S., Racagni G. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 14:1994;2924-2932.
75. Vornov J.J., Tasker R.C., Park J. Neurotoxicity of acute glutamate transport blockade depends on coactivation of both NMDA and AMPA/kainate receptors in organotypic hippocampal cultures. Exp. Neurol. 133:1995;7-17.
76. Watanabe H., Bannai S. Induction of cystine transport activity in mouse peritoneal macrophages. J. Exp. Med. 165:1987;628-640.
77. 13C ) glutamate Glia. 17:1996;160-168.
78. Yan S.-D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.
79. Yudkoff M., Nissim I., Daikhin Y., Lin Z.-P., Nelson D., Pleasure D., Erecinska M. Brain glutamate metabolism: Neuronal-astroglial relationship. Dev. Neurosci. 15:1993;343-350.